Manuel Litchman - Apr 24, 2022 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Role
President and CEO, Director
Signature
/s/ Manuel Litchman, M.D.
Stock symbol
MBIO
Transactions as of
Apr 24, 2022
Transactions value $
-$21,781
Form type
4
Date filed
6/4/2024, 08:33 PM
Previous filing
Apr 3, 2023
Next filing
Jul 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBIO Common Stock Tax liability -$15.2K -1.25K -1.52% $12.15* 81K Apr 24, 2022 Direct F1, F2, F4
transaction MBIO Common Stock Tax liability -$6.62K -1.57K -1.94% $4.21* 79.4K Apr 24, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1,248 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
F2 The amount of common stock reflected on this Form 4 has been adjusted to reflect a 1-for-15 reverse stock split that occurred subsequent to this transaction.
F3 1,572 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units.
F4 Includes 3,975 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2023 and September 1, 2023.